UAB research involving magic mushrooms gets funding boost

A drug development company focused on low-dose psychedelic-derived therapies is investing in University of Alabama at Birmingham research.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.